Lupin gets FDA approval for Suprax chewable tablets

Pharma company Lupin Ltd said its US subsidiary Lupin Pharmaceuticals Inc received US Food and Drug Administration (USFDA) approval for its Suprax (Cefixime) chewable tablets of 100mg, 150mg and 200mg strength.

Suprax is a drug to treat urinary tract infections in children, the company said in a statement.

On Tuesday, Lupin shares ended flat at Rs444 on the Bombay Stock Exchange, while the benchmark Sensex 0.1% down at 20,345 points.
 

User

JSW Energy to invest Rs3,300 crore in 660MW power plant at Vijayanagar

Power utility JSW Energy Ltd said it received approval from its board to develop a 660MW power plant at Vijayanagar in Karnataka at an estimated cost of Rs3,300 crore. The project will be funded with a debt-equity ratio of 3:1, JSW Energy said in a statement.

The company also received board approval to create a special purpose vehicle for its 240MW Kutehr hydroelectric power project being develop at Chamba district in Himachal Pradesh, it added.

On Tuesday, JSW Energy shares declined 0.7% to Rs118 on the Bombay Stock Exchange, while the benchmark Sensex 0.1% down at 20,345 points.
 

User

NALCO Q2 net profit jumps 40% to Rs224 crore

Aluminium manufacturer National Aluminium Co Ltd (NALCO) reported a 40% increase in net profit for the second quarter ended September 2010 on higher sales.

For the quarter to end-September, the aluminium producer reported a net profit of Rs224 crore from Rs159.5 crore same quarter last year.

During the September 2010 quarter, its net sales increased to Rs1,454.8 crore from Rs1,143.1 crore, while its total revenues stood at Rs1,479.2 crore as against Rs1,179.1 crore, NALCO said in a regulatory filing.

On Tuesday, NALCO shares declined 0.3% to Rs404 on the Bombay Stock Exchange, while the benchmark Sensex 0.1% down at 20,345 points.

User

We are listening!

Solve the equation and enter in the Captcha field.
  Loading...
Close

To continue


Please
Sign Up or Sign In
with

Email
Close

To continue


Please
Sign Up or Sign In
with

Email

BUY NOW

The Scam
24 Year Of The Scam: The Perennial Bestseller, reads like a Thriller!
Moneylife Magazine
Fiercely independent and pro-consumer information on personal finance
Stockletters in 3 Flavours
Outstanding research that beats mutual funds year after year
MAS: Complete Online Financial Advisory
(Includes Moneylife Magazine and Lion Stockletter)